Loophole in Hemp & Loophole in FSE ListingIt took CURA 4 yrs to see the loophole in hemp and are noe finally getting involved, let’s hope Boris starts selling the new hemp brand in all CURAS stores. So uplisting to the TSX did nothing and now the main reason we are not trading like other companies is because we can not get guidance from FinCEN because we are still considered a schedule 1 drug, and it may take years not month but years to get this moved to schedule 3. One place which Curaleaf is seeing massive growth and has legalized cannabis is Germany. German cannabis listed stocks have seen 4x growth since cannabis legalization passed on April 1st. Should Curaleaf list on the Frankfurt Stock Exchange? There would be zero barriers from major investment firms from investing into a Curaleaf because cannabis has been legalized and we are the largest cannabis company not just in Germany or Europe but the world. Time is money and we can de list when America gets their act together, which could be years away. Let’s enjoy a stock exchange where we do not have FinCEN issues and start trading where we should be. Germanys cannabis market is about to go parabolic. Germany is California, Florida and New York all in one country. A FSE Listing is the most logical move for the future of Curaleaf and its investors. Americas legal cannabis market is a disaster and Curaleaf needs to go where the legal issues have been solved and where major institutions can trade freely with out fear of any consequences. CURA FSE LETS GO!!!